From: Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional study
Variables | Groups | OR (95% CI) Referent | p-value Referent | |
---|---|---|---|---|
Recovery time ≤ 14 days N (%)* | Recovery time ≥ 15 N (%)* | |||
Normal CT scan | ||||
 Yes | 17 (8.8%) | 4 (2.5%) | 3.75 (1.23–11.37) | 0.02** |
 No | 177 (91.2%) | 156 (97.5%) | ||
Lactate dehydrogenase (units/L) | ||||
 < 480 | 29 (37.2%) | 35 (30.4%) | 1.35 (0.74–2.48) | 0.33 |
 ≥ 480 | 49 (62.8%) | 80 (69.6%) | ||
Creatine phosphokinase (units/L) | ||||
 < 195 | 44 (75.9%) | 75 (78.9%) | 0.84 (0.39–1.82) | Referent |
 ≥ 195 | 14 (24.1%) | 20 (21.1%) | 0.66 | |
AST (units/L) | ||||
 < 41 | 63 (63.6%) | 84 (67.2%) | 0.85 (0.49–1.49) | 0.58 |
 ≥ 41 | 36 (36.4%) | 41 (32.8%) | ||
ALT (units/L) | ||||
 < 41 | 63 (64.9%) | 86 (68.8%) | 0.84 (0.48–1.48) | 0.55 |
 ≥ 41 | 34 (35.1%) | 39 (31.2%) | ||
Erythrocyte sedimentation rate (ESR) (mm/h) | ||||
 ≤ 60 | 57 (41.6%) | 44 (30.1%) | 1.65 (1.01–2.70) | 0.05** |
 ≥ 61 | 80 (58.4%) | 102 (69.9%) | ||
C-reactive protein (CRP) (mg/L) | ||||
 ≤ 90 | 96 (62.3%) | 83 (52.9%) | 1.48 (0.94–2.32) | 0.09** |
 ≥ 91 | 58 (37.7%) | 74 (47.1%) | ||
Platelet (cell/mm3) | ||||
 < 150,000 | 41 (24.7%) | 39 (23.6%) | 0.94 (0.57–1.56) | 0.82 |
 ≥ 150,000 | 125 (75.3%) | 126 (76.4%) | ||
White blood cell (WBC) (cell/mm3) | ||||
 < 4000 | 26 (15.8%) | 23 (14.1%) | 0.10 (0.54–1.85) | 0.99 |
 4000–9999 | 117 (70.9%) | 103 (63.2%) | 1.90 (0.88–4.11) | 0.10 |
 ≥ 10,000 | 22 (13.3%) | 37 (22.7%) |  |  |
Lymphocyte count (cell/ mm3) | ||||
 ≤ 1000 | 56 (44.4%) | 64 (46.4%) | 1.08 (0.67–1.76) | 0.75 |
 > 1000 | 70 (55.6%) | 74 (53.6%) |